{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:41:40Z","timestamp":1791391300447,"version":"4.3.3"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2025ZD0547800"],"award-info":[{"award-number":["2025ZD0547800"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222007"],"award-info":[{"award-number":["82222007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170281"],"award-info":[{"award-number":["82170281"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U2004203"],"award-info":[{"award-number":["U2004203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Province Key R&D Program","award":["241111313300"],"award-info":[{"award-number":["241111313300"]}]},{"name":"Henan Province Science and Technology Research Joint Project","award":["222301420054"],"award-info":[{"award-number":["222301420054"]}]},{"DOI":"10.13039\/501100013057","name":"Innovation Scientists and Technicians Troop Construction Projects of Henan Province","doi-asserted-by":"publisher","award":["254000510006"],"award-info":[{"award-number":["254000510006"]}],"id":[{"id":"10.13039\/501100013057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Provincial Clinical Medical Scientist Training Project","award":["HNCMS202418"],"award-info":[{"award-number":["HNCMS202418"]}]},{"name":"Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["ZYCXTD2023008"],"award-info":[{"award-number":["ZYCXTD2023008"]}]},{"name":"Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University","award":["QNCXTD2023001"],"award-info":[{"award-number":["QNCXTD2023001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"DOI":"10.1007\/s00395-025-01156-3","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T13:10:41Z","timestamp":1768137041000},"page":"301-319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing"],"prefix":"10.1007","volume":"121","author":[{"given":"Yameng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinglan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","volume":"635","author":"JM Amrute","year":"2024","unstructured":"Amrute JM, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, Bredemeyer A, Jung I-H, Kadyrov FF, Heo GS, Venkatesan R, Shi SY, Parvathaneni A, Koenig AL, Kuppe C, Baker C, Luehmann H, Jones C, Kopecky B, Zeng X, Bleckwehl T, Ma P, Lee P, Terada Y, Fu A, Furtado M, Kreisel D, Kovacs A, Stitziel NO, Jackson S, Li C-M, Liu Y, Rosenthal NA, Kramann R, Ason B, Lavine KJ (2024) Targeting immune\u2013fibroblast cell communication in heart failure. Nature 635:423\u2013433. https:\/\/doi.org\/10.1038\/s41586-024-08008-5","journal-title":"Nature"},{"key":"1156_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41569-025-01165-8","volume":"22","author":"I Andreadou","year":"2025","unstructured":"Andreadou I, Ghigo A, Nikolaou PE, Swirski FK, Thackeray JT, Heusch G, Vilahur G (2025) Immunometabolism in heart failure. Nat Rev Cardiol 22:751\u2013772. https:\/\/doi.org\/10.1038\/s41569-025-01165-8","journal-title":"Nat Rev Cardiol"},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-022-05432-3","volume":"611","author":"ML Axelrod","year":"2022","unstructured":"Axelrod ML, Meijers WC, Screever EM, Qin J, Carroll MG, Sun X, Tannous E, Zhang Y, Sugiura A, Taylor BC, Hanna A, Zhang S, Amancherla K, Tai W, Wright JJ, Wei SC, Opalenik SR, Toren AL, Rathmell JC, Ferrell PB, Phillips EJ, Mallal S, Johnson DB, Allison JP, Moslehi JJ, Balko JM (2022) T cells specific for alpha-myosin drive immunotherapy-related myocarditis. Nature 611:818\u2013826. https:\/\/doi.org\/10.1038\/s41586-022-05432-3","journal-title":"Nature"},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.gpb.2021.02.004","volume":"19","author":"Z Bai","year":"2021","unstructured":"Bai Z, Su G, Fan R (2021) Single-cell analysis technologies for immuno-oncology research: from mechanistic delineation to biomarker discovery. Genomics Proteomics Bioinform 19:191\u2013207. https:\/\/doi.org\/10.1016\/j.gpb.2021.02.004","journal-title":"Genomics Proteomics Bioinform"},{"key":"1156_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-024-08105-5","volume":"636","author":"SM Blum","year":"2024","unstructured":"Blum SM, Zlotoff DA, Smith NP, Kernin IJ, Ramesh S, Zubiri L, Caplin J, Samanta N, Martin S, Wang M, Tirard A, Song Y, Xu KH, Barth J, Sen P, Slowikowski K, Tantivit J, Manakongtreecheep K, Arnold BY, Nasrallah M, Pinto CJ, McLoughlin D, Jackson M, Chan P, Lawless A, Michaud WA, Sharova T, Nieman LT, Gainor JF, Wu CJ, Juric D, Mino-Kenudson M, Oliveira G, Sullivan RJ, Boland GM, Stone JR, Thomas MF, Neilan TG, Reynolds KL, Villani AC (2024) Immune responses in checkpoint myocarditis across heart, blood and tumour. Nature 636:215\u2013223. https:\/\/doi.org\/10.1038\/s41586-024-08105-5","journal-title":"Nature"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa1504627","volume":"373","author":"J Brahmer","year":"2015","unstructured":"Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE, Holgado E, Waterhouse D, Ready N, Gainor J, Aren Frontera O, Havel L, Steins M, Garassino MC, Aerts JG, Domine M, Paz-Ares L, Reck M, Baudelet C, Harbison CT, Lestini B, Spigel DR (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373:123\u2013135. https:\/\/doi.org\/10.1056\/NEJMoa1504627","journal-title":"N Engl J Med"},{"key":"1156_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00395-024-01070-0","volume":"120","author":"F Buehning","year":"2024","unstructured":"Buehning F, Lerchner T, Vogel J, Hendgen-Cotta UB, Totzeck M, Rassaf T, Michel L (2024) Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapy. Basic Res Cardiol 120:171\u2013185. https:\/\/doi.org\/10.1007\/s00395-024-01070-0","journal-title":"Basic Res Cardiol"},{"key":"1156_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001887","author":"J Cautela","year":"2020","unstructured":"Cautela J, Zeriouh S, Gaubert M, Bonello L, Laine M, Peyrol M, Paganelli F, Lalevee N, Barlesi F, Thuny F (2020) Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-001887","journal-title":"J Immunother Cancer"},{"key":"1156_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00262-024-03899-9","volume":"74","author":"Y Chen","year":"2025","unstructured":"Chen Y, Luo Y, Liu Y, Luo D, Liu A (2025) Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study. Cancer Immunol Immunother 74:52. https:\/\/doi.org\/10.1007\/s00262-024-03899-9","journal-title":"Cancer Immunol Immunother"},{"key":"1156_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s00011-024-01979-1","volume":"74","author":"Y Chen","year":"2025","unstructured":"Chen Y, Luo Y, Liu Y, Qiu X, Luo D, Liu A (2025) Mediation of macrophage M1 polarization dynamics change by ubiquitin-autophagy-pathway regulated NLRP3 inflammasomes in PD-1 inhibitor-related myocardial inflammatory injury. Inflamm Res 74:56. https:\/\/doi.org\/10.1007\/s00011-024-01979-1","journal-title":"Inflamm Res"},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaccao.2019.08.005","volume":"1","author":"S Cuddy","year":"2019","unstructured":"Cuddy S, Payne DL, Murphy DJ, Dunne RM, Bueno R, Blankstein R, Di Carli M, Mehra MR, Nohria A, Groarke JD (2019) Incidental coronary artery calcification in cancer imaging. JACC: CardioOncology 1:135\u2013137. https:\/\/doi.org\/10.1016\/j.jaccao.2019.08.005","journal-title":"JACC: CardioOncology"},{"key":"1156_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007409","author":"E Daetwyler","year":"2024","unstructured":"Daetwyler E, Wallrabenstein T, Konig D, Cappelli LC, Naidoo J, Zippelius A, Laubli H (2024) Corticosteroid-resistant immune-related adverse events: a systematic review. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-007409","journal-title":"J Immunother Cancer"},{"key":"1156_CR13","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.0000017216.41471.df","volume":"105","author":"F de' Clari","year":"2002","unstructured":"de\u2019 Clari F, Salani I, Safwan E, Giannacco A (2002) Sudden death in a patient without heart failure after a single infusion of 200 mg infliximab: does TNF-alpha have protective effects on the failing heart, or does infliximab have direct harmful cardiovascular effects? Circulation 105:E183. https:\/\/doi.org\/10.1161\/01.cir.0000017216.41471.df","journal-title":"Circulation"},{"key":"1156_CR14","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s43018-024-00810-4","volume":"5","author":"F Dimitriou","year":"2024","unstructured":"Dimitriou F, Cheng PF, Saltari A, Schaper-Gerhardt K, Staeger R, Haunerdinger V, Sella F, Tastanova A, Urban C, Dettwiler S, Mihic-Probst D, Matter CM, Michielin O, Gutzmer R, Long GV, Becher B, Levesque MP, Dummer R (2024) A targetable type III immune response with increase of IL-17A expressing CD4(+) T cells is associated with immunotherapy-induced toxicity in melanoma. Nat Cancer 5:1390\u20131408. https:\/\/doi.org\/10.1038\/s43018-024-00810-4","journal-title":"Nat Cancer"},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00395-024-01046-0","volume":"120","author":"P Efentakis","year":"2025","unstructured":"Efentakis P, Choustoulaki A, Kwiatkowski G, Varela A, Kostopoulos IV, Tsekenis G, Ntanasis-Stathopoulos I, Georgoulis A, Vorgias CE, Gakiopoulou H, Briasoulis A, Davos CH, Kostomitsopoulos N, Tsitsilonis O, Dimopoulos MA, Terpos E, Chlopicki S, Gavriatopoulou M, Andreadou I (2025) Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin. Basic Res Cardiol 120:263\u2013286. https:\/\/doi.org\/10.1007\/s00395-024-01046-0","journal-title":"Basic Res Cardiol"},{"key":"1156_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","volume":"40","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, Schilling JD, Schwendener R, Sergin I, Razani B, Forsberg EC, Yokoyama WM, Unanue ER, Colonna M, Randolph GJ, Mann DL (2014) Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40:91\u2013104. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.019","journal-title":"Immunity"},{"key":"1156_CR17","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1056\/NEJMc1903064","volume":"380","author":"K Esfahani","year":"2019","unstructured":"Esfahani K, Buhlaiga N, Thebault P, Lapointe R, Johnson NA, Miller WH Jr. (2019) Alemtuzumab for immune-related myocarditis due to PD-1 therapy. N Engl J Med 380:2375\u20132376. https:\/\/doi.org\/10.1056\/NEJMc1903064","journal-title":"N Engl J Med"},{"key":"1156_CR18","doi-asserted-by":"publisher","first-page":"92 e91","DOI":"10.1016\/j.cjca.2017.09.025","volume":"34","author":"M Frigeri","year":"2018","unstructured":"Frigeri M, Meyer P, Banfi C, Giraud R, Hachulla AL, Spoerl D, Friedlaender A, Pugliesi-Rinaldi A, Dietrich PY (2018) Immune checkpoint inhibitor-associated myocarditis: a new challenge for cardiologists. Can J Cardiol 34:92 e91-92 e93. https:\/\/doi.org\/10.1016\/j.cjca.2017.09.025","journal-title":"Can J Cardiol"},{"key":"1156_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/jleuko\/qiad056","volume":"114","author":"J Gao","year":"2023","unstructured":"Gao J, Wang Y, Lu L, Ma M, Ling J, Sun L, Chen Y, Liu F, Yu Y, Liu T, Wu D (2023) Peripheral immune mapping and multi-omics analysis in Pd-1 inhibitor-induced myocarditis. J Leukoc Biol 114:164\u2013179. https:\/\/doi.org\/10.1093\/jleuko\/qiad056","journal-title":"J Leukoc Biol"},{"key":"1156_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00395-024-01068-8","volume":"120","author":"TG Gergely","year":"2025","unstructured":"Gergely TG, Drobni ZD, Sayour NV, Ferdinandy P, Varga ZV (2025) Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors. Basic Res Cardiol 120:187\u2013205. https:\/\/doi.org\/10.1007\/s00395-024-01068-8","journal-title":"Basic Res Cardiol"},{"key":"1156_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/bph.15984","volume":"180","author":"TG Gergely","year":"2023","unstructured":"Gergely TG, Kucsera D, Toth VE, Kovacs T, Sayour NV, Drobni ZD, Ruppert M, Petrovich B, Agg B, Onodi Z, Fekete N, Pallinger E, Buzas EI, Yousif LI, Meijers WC, Radovits T, Merkely B, Ferdinandy P, Varga ZV (2023) Characterization of immune checkpoint inhibitor-induced cardiotoxicity reveals interleukin-17A as a driver of cardiac dysfunction after anti-PD-1 treatment. Br J Pharmacol 180:740\u2013761. https:\/\/doi.org\/10.1111\/bph.15984","journal-title":"Br J Pharmacol"},{"key":"1156_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.aav3487","volume":"366","author":"C Gil-Cruz","year":"2019","unstructured":"Gil-Cruz C, Perez-Shibayama C, De Martin A, Ronchi F, van der Borght K, Niederer R, Onder L, L\u00fctge M, Novkovic M, Nindl V, Ramos G, Arnoldini M, Slack EMC, Boivin-Jahns V, Jahns R, Wyss M, Mooser C, Lambrecht BN, Maeder MT, Rickli H, Flatz L, Eriksson U, Geuking MB, McCoy KD, Ludewig B (2019) Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Science 366:881\u2013886. https:\/\/doi.org\/10.1126\/science.aav3487","journal-title":"Science"},{"key":"1156_CR23","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","volume":"70","author":"C Grani","year":"2017","unstructured":"Grani C, Eichhorn C, Biere L, Murthy VL, Agarwal V, Kaneko K, Cuddy S, Aghayev A, Steigner M, Blankstein R, Jerosch-Herold M, Kwong RY (2017) Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol 70:1964\u20131976. https:\/\/doi.org\/10.1016\/j.jacc.2017.08.050","journal-title":"J Am Coll Cardiol"},{"key":"1156_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg1323","volume":"16","author":"B Han","year":"2024","unstructured":"Han B, Zhou S, Zhang Y, Chen S, Xi W, Liu C, Zhou X, Yuan M, Yu X, Li L, Wang Y, Ren H, Xie J, Li B, Ju M, Zhou Y, Liu Z, Xiong Z, Shen L, Zhang Y, Bai Y, Chen J, Jiang W, Yao H (2024) Integrating spatial and single-cell transcriptomics to characterize the molecular and cellular architecture of the ischemic mouse brain. Sci Transl Med 16:eadg1323. https:\/\/doi.org\/10.1126\/scitranslmed.adg1323","journal-title":"Sci Transl Med"},{"key":"1156_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114676","volume":"156","author":"X He","year":"2025","unstructured":"He X, Zhang J, Zhang Y, Li H, Chen Y, Zhang H, Pan J, Zhou Y, Zhang S, Cheng L (2025) L-kynurenine regulates immune response in ICIs-associated myocarditis via JAK\/STAT pathway. Int Immunopharmacol 156:114676. https:\/\/doi.org\/10.1016\/j.intimp.2025.114676","journal-title":"Int Immunopharmacol"},{"key":"1156_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","volume":"43","author":"J Herrmann","year":"2022","unstructured":"Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, Lopez-Fernandez T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O\u2019Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P (2022) Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J 43:280\u2013299. https:\/\/doi.org\/10.1093\/eurheartj\/ehab674","journal-title":"Eur Heart J"},{"key":"1156_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-022-00909-8","volume":"117","author":"G Heusch","year":"2022","unstructured":"Heusch G (2022) Coronary blood flow in heart failure: cause, consequence and bystander. Basic Res Cardiol 117:1. https:\/\/doi.org\/10.1007\/s00395-022-00909-8","journal-title":"Basic Res Cardiol"},{"key":"1156_CR28","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41569-024-01114-x","volume":"22","author":"G Heusch","year":"2025","unstructured":"Heusch G, Kleinbongard P (2025) The spleen in ischaemic heart disease. Nat Rev Cardiol 22:497\u2013509. https:\/\/doi.org\/10.1038\/s41569-024-01114-x","journal-title":"Nat Rev Cardiol"},{"key":"1156_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1161\/CIRCRESAHA.124.325652","volume":"136","author":"YV Huang","year":"2025","unstructured":"Huang YV, Sun Y, Chou H, Wagner N, Vitale MR, Bayer AL, Xu B, Lee D, Lin Z, Branche C, Waliany S, Neal JW, Wakelee HA, Witteles RM, Nguyen PK, Graves EE, Berry GJ, Alcaide P, Wu SM, Zhu H (2025) Novel therapeutic approach targeting CXCR3 to treat immunotherapy myocarditis. Circ Res 136:473\u2013490. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.325652","journal-title":"Circ Res"},{"key":"1156_CR30","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41592-024-02243-4","volume":"21","author":"SE Irac","year":"2024","unstructured":"Irac SE, Soon MSF, Borcherding N, Tuong ZK (2024) Single-cell immune repertoire analysis. Nat Methods 21:777\u2013792. https:\/\/doi.org\/10.1038\/s41592-024-02243-4","journal-title":"Nat Methods"},{"key":"1156_CR31","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s44161-025-00633-1","volume":"4","author":"J Jimenez","year":"2025","unstructured":"Jimenez J, Amrute J, Ma P, Wang X, Das S, Dai R, Komaru Y, Herrlich A, Mack M, Lavine KJ (2025) The immune checkpoint regulator CD40 potentiates myocardial inflammation. Nat Cardiovasc Res 4:458\u2013472. https:\/\/doi.org\/10.1038\/s44161-025-00633-1","journal-title":"Nat Cardiovasc Res"},{"key":"1156_CR32","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa1609214","volume":"375","author":"DB Johnson","year":"2016","unstructured":"Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA Jr., Anders RA, Sosman JA, Moslehi JJ (2016) Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 375:1749\u20131755. https:\/\/doi.org\/10.1056\/NEJMoa1609214","journal-title":"N Engl J Med"},{"key":"1156_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.694","volume":"12","author":"D Jovic","year":"2022","unstructured":"Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y (2022) Single-cell RNA sequencing technologies and applications: a brief overview. Clin Transl Med 12:e694. https:\/\/doi.org\/10.1002\/ctm2.694","journal-title":"Clin Transl Med"},{"key":"1156_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2323052121","volume":"121","author":"H Kalinoski","year":"2024","unstructured":"Kalinoski H, Daoud A, Rusinkevich V, Jurcova I, Talor MV, Welsh RA, Hughes D, Zemanova K, Striz I, Hooper JE, Kautzner J, Peichl P, Melenovsky V, Won T, Cihakova D (2024) Injury-induced myosin-specific tissue-resident memory T cells drive immune checkpoint inhibitor myocarditis. Proc Natl Acad Sci U S A 121:e2323052121. https:\/\/doi.org\/10.1073\/pnas.2323052121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1156_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.7326\/0003-4819-138-10-200305200-00008","volume":"138","author":"HJ Kwon","year":"2003","unstructured":"Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138:807\u2013811. https:\/\/doi.org\/10.7326\/0003-4819-138-10-200305200-00008","journal-title":"Ann Intern Med"},{"key":"1156_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1200\/JCO.2016.71.8023","volume":"36","author":"J Larkin","year":"2018","unstructured":"Larkin J, Minor D, D\u2019Angelo S, Neyns B, Smylie M, Miller WH Jr., Gutzmer R, Linette G, Chmielowski B, Lao CD, Lorigan P, Grossmann K, Hassel JC, Sznol M, Daud A, Sosman J, Khushalani N, Schadendorf D, Hoeller C, Walker D, Kong G, Horak C, Weber J (2018) Overall survival in patients with advanced melanoma who received Nivolumab versus investigator\u2019s choice chemotherapy in CheckMate 037: a randomized, controlled, open-label phase III trial. J Clin Oncol 36:383\u2013390. https:\/\/doi.org\/10.1200\/JCO.2016.71.8023","journal-title":"J Clin Oncol"},{"key":"1156_CR37","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.1073\/pnas.1406508111","volume":"111","author":"KJ Lavine","year":"2014","unstructured":"Lavine KJ, Epelman S, Uchida K, Weber KJ, Nichols CG, Schilling JD, Ornitz DM, Randolph GJ, Mann DL (2014) Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc Natl Acad Sci U S A 111:16029\u201316034. https:\/\/doi.org\/10.1073\/pnas.1406508111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1156_CR38","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1161\/CIRCRESAHA.115.308270","volume":"118","author":"J Leid","year":"2016","unstructured":"Leid J, Carrelha J, Boukarabila H, Epelman S, Jacobsen SE, Lavine KJ (2016) Primitive embryonic macrophages are required for coronary development and maturation. Circ Res 118:1498\u20131511. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.308270","journal-title":"Circ Res"},{"key":"1156_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00395-024-01092-8","volume":"120","author":"AS Leven","year":"2025","unstructured":"Leven AS, Wagner N, Nienaber S, Messiha D, Tasdogan A, Ugurel S (2025) Changes in tumor and cardiac metabolism upon immune checkpoint. Basic Res Cardiol 120:133\u2013152. https:\/\/doi.org\/10.1007\/s00395-024-01092-8","journal-title":"Basic Res Cardiol"},{"key":"1156_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.semcancer.2025.09.006","volume":"116","author":"J Li","year":"2025","unstructured":"Li J, Chen L, Liu X, Zhang M, Liu X (2025) Molecular mechanisms and therapies of immune checkpoint inhibitor associated myocarditis: update on recent developments. Semin Cancer Biol 116:108\u2013120. https:\/\/doi.org\/10.1016\/j.semcancer.2025.09.006","journal-title":"Semin Cancer Biol"},{"key":"1156_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00395-024-01089-3","volume":"120","author":"S Li","year":"2025","unstructured":"Li S, Tajiri K, Yuan Z, Murakata Y, Song Z, Mizuno S, Xu D, Murakoshi N (2025) 4E-BP3 deficiency impairs dendritic cell activation and CD4(+) T cell differentiation and attenuates alpha-myosin-specific T cell-mediated myocarditis in mice. Basic Res Cardiol 120:225\u2013240. https:\/\/doi.org\/10.1007\/s00395-024-01089-3","journal-title":"Basic Res Cardiol"},{"key":"1156_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.697412","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Qu S, Zhang T, Gao Y, Shi H, Song K, Chen W, Yin W (2021) Applications of single-cell omics in tumor immunology. Front Immunol 12:697412. https:\/\/doi.org\/10.3389\/fimmu.2021.697412","journal-title":"Front Immunol"},{"key":"1156_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-015-0053-y","volume":"7","author":"R Liu","year":"2015","unstructured":"Liu R, Yu X, Wallqvist A (2015) Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries. J Cheminform 7:4. https:\/\/doi.org\/10.1186\/s13321-015-0053-y","journal-title":"J Cheminform"},{"key":"1156_CR44","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010568","author":"A Losurdo","year":"2025","unstructured":"Losurdo A, Panico C, Catalano C, Serio S, Giordano L, Monti L, Catapano F, Figliozzi S, D\u2019Andrea C, Dipasquale A, Persico P, Di Muzio A, Cremonesi M, Marchese A, Tronconi MC, Perrino M, Finocchiaro G, Lugli E, Francone M, Santoro A, Condorelli G, Simonelli M, Kallikourdis M (2025) Cardiac MRI study of adverse events in patients treated with immune checkpoint inhibitors: a prospective cohort study of cardiac adverse events. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-010568","journal-title":"J Immunother Cancer"},{"key":"1156_CR45","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/imm.13770","volume":"172","author":"B Lou","year":"2024","unstructured":"Lou B, Guo M, Zheng T, Liu J, Wang C, Chen T, Chen F, Fan X, Gao S, Liang X, Qiang H, Li L, Zhou B, Yuan Z, She J (2024) Single-cell RNA sequencing reveals the altered innate immunity in immune checkpoint inhibitor-related myocarditis. Immunology 172:235\u2013251. https:\/\/doi.org\/10.1111\/imm.13770","journal-title":"Immunology"},{"key":"1156_CR46","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010127","author":"Y Lu","year":"2025","unstructured":"Lu Y, Gao J, Hou Y, Yang H, Wang D, Zhang G, Qin Z, Du P, Wang Z, Wang Y, Chen Q, Sun Z, Li P, Zhang J, Tang J (2025) Targeting the NLRP3 inflammasome abrogates cardiotoxicity of immune checkpoint blockers. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2024-010127","journal-title":"J Immunother Cancer"},{"key":"1156_CR47","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.122.062551","volume":"149","author":"P Ma","year":"2024","unstructured":"Ma P, Liu J, Qin J, Lai L, Heo GS, Luehmann H, Sultan D, Bredemeyer A, Bajapa G, Feng G, Jimenez J, He R, Parks A, Amrute J, Villanueva A, Liu Y, Lin CY, Mack M, Amancherla K, Moslehi J, Lavine KJ (2024) Expansion of pathogenic cardiac macrophages in immune checkpoint inhibitor myocarditis. Circulation 149:48\u201366. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062551","journal-title":"Circulation"},{"key":"1156_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1365-2567.2005.02145.x","volume":"115","author":"L Macon-Lemaitre","year":"2005","unstructured":"Macon-Lemaitre L, Triebel F (2005) The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells. Immunology 115:170\u2013178. https:\/\/doi.org\/10.1111\/j.1365-2567.2005.02145.x","journal-title":"Immunology"},{"key":"1156_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1455347","volume":"16","author":"X Man","year":"2025","unstructured":"Man X, Wang H, Chen C, Cong X, Sun L, Sun X, Chen C, Zhang J, Yang L (2025) Efficacy of high-dose steroids versus low-dose steroids in the treatment of immune checkpoint inhibitor-associated myocarditis: a case series and systematic review. Front Immunol 16:1455347. https:\/\/doi.org\/10.3389\/fimmu.2025.1455347","journal-title":"Front Immunol"},{"key":"1156_CR50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2404661121","volume":"121","author":"S Mok","year":"2024","unstructured":"Mok S, Agac Cobanoglu D, Liu H, Mancuso JJ, Allison JP (2024) Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacy. Proc Natl Acad Sci U S A 121:e2404661121. https:\/\/doi.org\/10.1073\/pnas.2404661121","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1156_CR51","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/nmeth.1226","volume":"5","author":"A Mortazavi","year":"2008","unstructured":"Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5:621\u2013628. https:\/\/doi.org\/10.1038\/nmeth.1226","journal-title":"Nat Methods"},{"key":"1156_CR52","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","volume":"391","author":"JJ Moslehi","year":"2018","unstructured":"Moslehi JJ, Salem JE, Sosman JA, Lebrun-Vignes B, Johnson DB (2018) Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet 391:933. https:\/\/doi.org\/10.1016\/S0140-6736(18)30533-6","journal-title":"Lancet"},{"key":"1156_CR53","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002591","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Koyama S (2021) Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002591","journal-title":"J Immunother Cancer"},{"key":"1156_CR54","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1126\/science.291.5502.319","volume":"291","author":"H Nishimura","year":"2001","unstructured":"Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, Honjo T (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291:319\u2013322. https:\/\/doi.org\/10.1126\/science.291.5502.319","journal-title":"Science"},{"key":"1156_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0296-4","volume":"5","author":"TG Norwood","year":"2017","unstructured":"Norwood TG, Westbrook BC, Johnson DB, Litovsky SH, Terry NL, McKee SB, Gertler AS, Moslehi JJ, Conry RM (2017) Smoldering myocarditis following immune checkpoint blockade. J Immunother Cancer 5:91. https:\/\/doi.org\/10.1186\/s40425-017-0296-4","journal-title":"J Immunother Cancer"},{"key":"1156_CR56","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/nm955","volume":"9","author":"T Okazaki","year":"2003","unstructured":"Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T (2003) Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nat Med 9:1477\u20131483. https:\/\/doi.org\/10.1038\/nm955","journal-title":"Nat Med"},{"key":"1156_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-020-0359-y","volume":"17","author":"DT Paik","year":"2020","unstructured":"Paik DT, Cho S, Tian L, Chang HY, Wu JC (2020) Single-cell RNA sequencing in cardiovascular development, disease and medicine. Nat Rev Cardiol 17:457\u2013473. https:\/\/doi.org\/10.1038\/s41569-020-0359-y","journal-title":"Nat Rev Cardiol"},{"key":"1156_CR58","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.119.013757","author":"N Palaskas","year":"2020","unstructured":"Palaskas N, Lopez-Mattei J, Durand JB, Iliescu C, Deswal A (2020) Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.119.013757","journal-title":"J Am Heart Assoc"},{"key":"1156_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00395-024-01077-7","volume":"120","author":"G Panuccio","year":"2025","unstructured":"Panuccio G, Correale P, d\u2019Apolito M, Mutti L, Giannicola R, Pirtoli L, Giordano A, Labate D, Macheda S, Carabetta N, Abdelwahed YS, Landmesser U, Tassone P, Tagliaferri P, De Rosa S, Torella D (2025) Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients. Basic Res Cardiol 120:153\u2013169. https:\/\/doi.org\/10.1007\/s00395-024-01077-7","journal-title":"Basic Res Cardiol"},{"key":"1156_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2024.12.017","author":"M Pereyra Pietri","year":"2025","unstructured":"Pereyra Pietri M, Farina JM, Scalia IG, Roarke M, Mahmoud AK, Masson R, Wasef B, Tagle-Cornell C, Kenyon CR, Abbas MT, Baba Ali N, Awad K, Kamel MA, Said EF, O\u2019Shea M, Barry T, Narayanasamy H, Ray JC, El Masry H, Larsen CM, Herrmann J, Arsanjani R, Ayoub C (2025) Characterization of cardiovascular events and prognosis in immune checkpoint inhibitor-related myocarditis. Mayo Clin Proc. https:\/\/doi.org\/10.1016\/j.mayocp.2024.12.017","journal-title":"Mayo Clin Proc"},{"key":"1156_CR61","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.2411","volume":"3","author":"T Powles","year":"2017","unstructured":"Powles T, O\u2019Donnell PH, Massard C, Arkenau HT, Friedlander TW, Hoimes CJ, Lee JL, Ong M, Sridhar SS, Vogelzang NJ, Fishman MN, Zhang J, Srinivas S, Parikh J, Antal J, Jin X, Gupta AK, Ben Y, Hahn NM (2017) Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: updated results from a phase 1\/2 open-label study. JAMA Oncol 3:e172411. https:\/\/doi.org\/10.1001\/jamaoncol.2017.2411","journal-title":"JAMA Oncol"},{"key":"1156_CR62","doi-asserted-by":"publisher","first-page":"D285","DOI":"10.1093\/nar\/gkad924","volume":"52","author":"FC Qian","year":"2024","unstructured":"Qian FC, Zhou LW, Zhu YB, Li YY, Yu ZM, Feng CC, Fang QL, Zhao Y, Cai FH, Wang QY, Tang HF, Li CQ (2024) scATAC-Ref: a reference of scATAC-seq with known cell labels in multiple species. Nucleic Acids Res 52:D285\u2013D292. https:\/\/doi.org\/10.1093\/nar\/gkad924","journal-title":"Nucleic Acids Res"},{"key":"1156_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10040179","author":"V Quagliariello","year":"2020","unstructured":"Quagliariello V, Passariello M, Rea D, Barbieri A, Iovine M, Bonelli A, Caronna A, Botti G, De Lorenzo C, Maurea N (2020) Evidences of CTLA-4 and PD-1 blocking agents-induced cardiotoxicity in cellular and preclinical models. J Pers Med. https:\/\/doi.org\/10.3390\/jpm10040179","journal-title":"J Pers Med"},{"key":"1156_CR64","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.2300841","volume":"212","author":"JJ Racine","year":"2024","unstructured":"Racine JJ, Bachman JF, Zhang J-G, Misherghi A, Khadour R, Kaisar S, Bedard O, Jenkins C, Abbott A, Forte E, Rainer P, Rosenthal N, Sattler S, Serreze DV (2024) Murine MHC-deficient nonobese diabetic mice carrying human HLA-DQ8 develop severe myocarditis and myositis in response to anti\u2013PD-1 immune checkpoint inhibitor cancer therapy. J Immunol 212:1287\u20131306. https:\/\/doi.org\/10.4049\/jimmunol.2300841","journal-title":"J Immunol"},{"key":"1156_CR65","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, Csoszi T, Fulop A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O\u2019Brien M, Rao S, Hotta K, Leiby MA, Lubiniecki GM, Shentu Y, Rangwala R, Brahmer JR, Investigators K- (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375:1823\u20131833. https:\/\/doi.org\/10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"key":"1156_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15172-5","author":"M Ren","year":"2020","unstructured":"Ren M, Kazemian M, Zheng M, He J, Li P, Oh J, Liao W, Li J, Rajaseelan J, Kelsall BL, Peltz G, Leonard WJ (2020) Transcription factor p73 regulates Th1 differentiation. Nature Commun. https:\/\/doi.org\/10.1038\/s41467-020-15172-5","journal-title":"Nature Commun"},{"key":"1156_CR67","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","volume":"389","author":"A Rittmeyer","year":"2017","unstructured":"Rittmeyer A, Barlesi F, Waterkamp D, Park K, Ciardiello F, von Pawel J, Gadgeel SM, Hida T, Kowalski DM, Dols MC, Cortinovis DL, Leach J, Polikoff J, Barrios C, Kabbinavar F, Frontera OA, De Marinis F, Turna H, Lee JS, Ballinger M, Kowanetz M, He P, Chen DS, Sandler A, Gandara DR, Group OAKS (2017) Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. Lancet 389:255\u2013265. https:\/\/doi.org\/10.1016\/S0140-6736(16)32517-X","journal-title":"Lancet"},{"key":"1156_CR68","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1182\/blood-2017-06-741033","volume":"131","author":"B Rowshanravan","year":"2018","unstructured":"Rowshanravan B, Halliday N, Sansom DM (2018) CTLA-4: a moving target in immunotherapy. Blood 131:58\u201367. https:\/\/doi.org\/10.1182\/blood-2017-06-741033","journal-title":"Blood"},{"key":"1156_CR69","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/ehf2.14614","volume":"11","author":"N Rubio-Infante","year":"2024","unstructured":"Rubio-Infante N, Castillo EC, Alves-Figueiredo H, Ramos-Gonzalez M, Salazar-Ramirez F, Salas-Trevino D, Soto-Dominguez A, Lozano O, Garcia-Rivas G, Torre-Amione G (2024) Previous cardiovascular injury is a prerequisite for immune checkpoint inhibitor-associated lethal myocarditis in mice. ESC Heart Fail 11:1249\u20131257. https:\/\/doi.org\/10.1002\/ehf2.14614","journal-title":"ESC Heart Fail"},{"key":"1156_CR70","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMc1901677","volume":"380","author":"JE Salem","year":"2019","unstructured":"Salem JE, Allenbach Y, Vozy A, Brechot N, Johnson DB, Moslehi JJ, Kerneis M (2019) Abatacept for severe immune checkpoint inhibitor-associated myocarditis. N Engl J Med 380:2377\u20132379. https:\/\/doi.org\/10.1056\/NEJMc1901677","journal-title":"N Engl J Med"},{"key":"1156_CR71","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","volume":"19","author":"JE Salem","year":"2018","unstructured":"Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, Gobert A, Spano JP, Balko JM, Bonaca MP, Roden DM, Johnson DB, Moslehi JJ (2018) Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study. Lancet Oncol 19:1579\u20131589. https:\/\/doi.org\/10.1016\/S1470-2045(18)30608-9","journal-title":"Lancet Oncol"},{"key":"1156_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00395-024-01088-4","volume":"120","author":"NV Sayour","year":"2025","unstructured":"Sayour NV, Kucsera D, Alhaddad AR, Toth VE, Gergely TG, Kovacs T, Hegedus ZI, Jakab ME, Ferdinandy P, Varga ZV (2025) Effects of sex and obesity on immune checkpoint inhibition-related cardiac systolic dysfunction in aged mice. Basic Res Cardiol 120:207\u2013223. https:\/\/doi.org\/10.1007\/s00395-024-01088-4","journal-title":"Basic Res Cardiol"},{"key":"1156_CR73","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","volume":"33","author":"D Schadendorf","year":"2015","unstructured":"Schadendorf D, Hodi FS, Robert C, Weber JS, Margolin K, Hamid O, Patt D, Chen TT, Berman DM, Wolchok JD (2015) Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J Clin Oncol 33:1889\u20131894. https:\/\/doi.org\/10.1200\/JCO.2014.56.2736","journal-title":"J Clin Oncol"},{"key":"1156_CR74","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1158\/2326-6066.CIR-24-0011","volume":"12","author":"BA Siddiqui","year":"2024","unstructured":"Siddiqui BA, Palaskas NL, Basu S, Dai Y, He Z, Yadav SS, Allison JP, Sheth RA, Tummala S, Buja M, Bhattacharjee MB, Iliescu C, Rawther-Karedath A, Deswal A, Wang L, Sharma P, Subudhi SK (2024) Molecular pathways and cellular subsets associated with adverse clinical outcomes in overlapping immune-related myocarditis and myositis. Cancer Immunol Res 12:964\u2013987. https:\/\/doi.org\/10.1158\/2326-6066.CIR-24-0011","journal-title":"Cancer Immunol Res"},{"key":"1156_CR75","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/nmeth.4380","volume":"14","author":"M Stoeckius","year":"2017","unstructured":"Stoeckius M, Hafemeister C, Stephenson W, Houck-Loomis B, Chattopadhyay PK, Swerdlow H, Satija R, Smibert P (2017) Simultaneous epitope and transcriptome measurement in single cells. Nat Methods 14:865\u2013868. https:\/\/doi.org\/10.1038\/nmeth.4380","journal-title":"Nat Methods"},{"key":"1156_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06551-x","volume":"23","author":"B Sun","year":"2025","unstructured":"Sun B, Xun Z, Zhou Z, Zhang N, Piao M, Li C, Li J, Li S, Zhang L, Chen X, Wang H, Zhao H (2025) Single-cell transcriptomic analysis deciphers the inflammatory microenvironment characterized by CXCL9+ fibroblasts and ACKR1+ endothelial cells in immune-related myocarditis. J Transl Med 23:555. https:\/\/doi.org\/10.1186\/s12967-025-06551-x","journal-title":"J Transl Med"},{"key":"1156_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02298-1","author":"J Sun","year":"2025","unstructured":"Sun J, Wu W, Wang Y, Zhang J, Qiu S, Guan Z, Shi C, Ma J, Xu Y (2025) MLKL-Mediated necroptosis predominantly contributes to immune-associated myocardial damage. Inflammation. https:\/\/doi.org\/10.1007\/s10753-025-02298-1","journal-title":"Inflammation"},{"key":"1156_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00455-6","volume":"6","author":"K Sun","year":"2021","unstructured":"Sun K, Li YY, Jin J (2021) A double-edged sword of immuno-microenvironment in cardiac homeostasis and injury repair. Signal Transduct Target Ther 6:79. https:\/\/doi.org\/10.1038\/s41392-020-00455-6","journal-title":"Signal Transduct Target Ther"},{"key":"1156_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01471-y","author":"L Sun","year":"2023","unstructured":"Sun L, Su Y, Jiao A, Wang X, Zhang B (2023) T cells in health and disease. Signal Transd Target Therapy. https:\/\/doi.org\/10.1038\/s41392-023-01471-y","journal-title":"Signal Transd Target Therapy"},{"key":"1156_CR80","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/bjc.2017.253","volume":"117","author":"RY Tay","year":"2017","unstructured":"Tay RY, Blackley E, McLean C, Moore M, Bergin P, Gill S, Haydon A (2017) Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy. Br J Cancer 117:921\u2013924. https:\/\/doi.org\/10.1038\/bjc.2017.253","journal-title":"Br J Cancer"},{"key":"1156_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072399","author":"WT Tay","year":"2020","unstructured":"Tay WT, Fang YH, Beh ST, Liu YW, Hsu LW, Yen CJ, Liu PY (2020) Programmed cell death-1: programmed cell death-ligand 1 interaction protects human cardiomyocytes against T-cell mediated inflammation and apoptosis response in vitro. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21072399","journal-title":"Int J Mol Sci"},{"key":"1156_CR82","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.125.073836","author":"Z Tong","year":"2025","unstructured":"Tong Z, Yan X, Chen T, Song W, Su D, Wang N, Zhang Y, Kong Y, Wang D, Wang P, Chen Y, Wang X, Cui J, Sui J, Liu S, Li Y, Yang Q, Zheng Z, Jin Z, Li Y, Liu F, Li J, Qi L, Deng J, Li Z, Yang S, Jia H, Ji Y, Zhang M, Yu B (2025) Single-cell multi-omics identifies specialized cytotoxic and migratory CD8+ effector T cells in acute myocarditis. Circulation. https:\/\/doi.org\/10.1161\/circulationaha.125.073836","journal-title":"Circulation"},{"key":"1156_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02852","volume":"10","author":"D van der Heide","year":"2019","unstructured":"van der Heide D, Weiskirchen R, Bansal R (2019) Therapeutic targeting of hepatic macrophages for the treatment of liver diseases. Front Immunol 10:2852. https:\/\/doi.org\/10.3389\/fimmu.2019.02852","journal-title":"Front Immunol"},{"key":"1156_CR84","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","volume":"9","author":"SJ Wang","year":"2023","unstructured":"Wang SJ, Dougan SK, Dougan M (2023) Immune mechanisms of toxicity from checkpoint inhibitors. Trends Cancer 9:543\u2013553. https:\/\/doi.org\/10.1016\/j.trecan.2023.04.002","journal-title":"Trends Cancer"},{"key":"1156_CR85","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/2159-8290.CD-20-0856","volume":"11","author":"SC Wei","year":"2021","unstructured":"Wei SC, Meijers WC, Axelrod ML, Anang NAS, Screever EM, Wescott EC, Johnson DB, Whitley E, Lehmann L, Courand PY, Mancuso JJ, Himmel LE, Lebrun-Vignes B, Wleklinski MJ, Knollmann BC, Srinivasan J, Li Y, Atolagbe OT, Rao X, Zhao Y, Wang J, Ehrlich LIR, Sharma P, Salem JE, Balko JM, Moslehi JJ, Allison JP (2021) A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention. Cancer Discov 11:614\u2013625. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0856","journal-title":"Cancer Discov"},{"key":"1156_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111611","volume":"41","author":"T Won","year":"2022","unstructured":"Won T, Kalinoski HM, Wood MK, Hughes DM, Jaime CM, Delgado P, Talor MV, Lasrado N, Reddy J, Cihakova D (2022) Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis. Cell Rep 41:111611. https:\/\/doi.org\/10.1016\/j.celrep.2022.111611","journal-title":"Cell Rep"},{"key":"1156_CR87","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/s44161-022-00184-9","volume":"1","author":"A Wong","year":"2022","unstructured":"Wong A, Epelman S (2022) Unchecked autoreactive CD8+ T cells wreak havoc in cancer immunotherapy. Nat Cardiovasc Res 1:1111\u20131113. https:\/\/doi.org\/10.1038\/s44161-022-00184-9","journal-title":"Nat Cardiovasc Res"},{"key":"1156_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010107","author":"CK Wong","year":"2023","unstructured":"Wong CK, Lam TH, Liao SY, Lau YM, Tse HF, So BYF (2023) Immunopathogenesis of immune checkpoint inhibitor induced myocarditis: insights from experimental models and treatment implications. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11010107","journal-title":"Biomedicines"},{"key":"1156_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400486","volume":"11","author":"MM Wu","year":"2024","unstructured":"Wu MM, Yang YC, Cai YX, Jiang S, Xiao H, Miao C, Jin XY, Sun Y, Bi X, Hong Z, Zhu D, Yu M, Mao JJ, Yu CJ, Liang C, Tang LL, Wang QS, Shao Q, Jiang QH, Pan ZW, Zhang ZR (2024) Anti-CTLA-4 m2a antibody exacerbates cardiac injury in experimental autoimmune myocarditis mice by promoting Ccl5-neutrophil infiltration. Adv Sci Weinh 11:e2400486. https:\/\/doi.org\/10.1002\/advs.202400486","journal-title":"Adv Sci Weinh"},{"key":"1156_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00643-4","volume":"12","author":"X Wu","year":"2024","unstructured":"Wu X, Yang X, Dai Y, Zhao Z, Zhu J, Guo H, Yang R (2024) Single-cell sequencing to multi-omics: technologies and applications. Biomark Res 12:110. https:\/\/doi.org\/10.1186\/s40364-024-00643-4","journal-title":"Biomark Res"},{"key":"1156_CR91","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ccell.2024.03.001","volume":"42","author":"G Xue","year":"2024","unstructured":"Xue G, Li X, Kalim M, Fang J, Jiang Z, Zheng N, Wang Z, Li X, Abdelrahim M, He Z, Nikiforov M, Jin G, Lu Y (2024) Clinical drug screening reveals clofazimine potentiates the efficacy while reducing the toxicity of anti-PD-1 and CTLA-4 immunotherapy. Cancer Cell 42:780-796 e786. https:\/\/doi.org\/10.1016\/j.ccell.2024.03.001","journal-title":"Cancer Cell"},{"key":"1156_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1167975","volume":"14","author":"Q Yin","year":"2023","unstructured":"Yin Q, Wu L, Han L, Zheng X, Tong R, Li L, Bai L, Bian Y (2023) Immune-related adverse events of immune checkpoint inhibitors: a review. Front Immunol 14:1167975. https:\/\/doi.org\/10.3389\/fimmu.2023.1167975","journal-title":"Front Immunol"},{"key":"1156_CR93","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.immuni.2010.09.006","volume":"33","author":"T Yokosuka","year":"2010","unstructured":"Yokosuka T, Kobayashi W, Takamatsu M, Sakata-Sogawa K, Zeng H, Hashimoto-Tane A, Yagita H, Tokunaga M, Saito T (2010) Spatiotemporal basis of CTLA-4 costimulatory molecule-mediated negative regulation of T cell activation. Immunity 33:326\u2013339. https:\/\/doi.org\/10.1016\/j.immuni.2010.09.006","journal-title":"Immunity"},{"key":"1156_CR94","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/cvr\/cvae133","volume":"120","author":"J Yu","year":"2024","unstructured":"Yu J, Long B, Li Z, Tian X, Li D, Long J, Wang Y, Chen Y, Zhang F, Liu H, Qian C, Shan J (2024) Central memory CD4+ T cells play a protective role against immune checkpoint inhibitor-associated myocarditis. Cardiovasc Res 120:1442\u20131455. https:\/\/doi.org\/10.1093\/cvr\/cvae133","journal-title":"Cardiovasc Res"},{"key":"1156_CR95","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41467-023-36635-5","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu X, Xu X, Zhang J, Li X (2023) Batch alignment of single-cell transcriptomics data using deep metric learning. Nat Commun 14:960. https:\/\/doi.org\/10.1038\/s41467-023-36635-5","journal-title":"Nat Commun"},{"key":"1156_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114263","volume":"150","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Cao Z, Jia H, Feng Y, Sun X, Wu H, Xu B, Wei Z (2025) Immune checkpoint inhibitor induces cardiac injury by impairing efferocytosis of macrophages via mertk cleavage. Int Immunopharmacol 150:114263. https:\/\/doi.org\/10.1016\/j.intimp.2025.114263","journal-title":"Int Immunopharmacol"},{"key":"1156_CR97","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR (2007) IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8:967\u2013974. https:\/\/doi.org\/10.1038\/ni1488","journal-title":"Nat Immunol"},{"key":"1156_CR98","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1161\/CIRCULATIONAHA.121.056730","volume":"146","author":"H Zhu","year":"2022","unstructured":"Zhu H, Galdos FX, Lee D, Waliany S, Huang YV, Ryan J, Dang K, Neal JW, Wakelee HA, Reddy SA, Srinivas S, Lin LL, Witteles RM, Maecker HT, Davis MM, Nguyen PK, Wu SM (2022) Identification of pathogenic immune cell subsets associated with checkpoint inhibitor-induced myocarditis. Circulation 146:316\u2013335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056730","journal-title":"Circulation"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-025-01156-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-025-01156-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-025-01156-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:59:27Z","timestamp":1773831567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-025-01156-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":98,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1007\/s00395-025-01156-3","relation":{},"ISSN":["1435-1803"],"issn-type":[{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}